The Global Dual Balloon Angioplasty Catheter Industry is on track for a period of consistent growth, marking a significant development in the treatment of coronary artery diseases. According to a recent analysis, the market value is projected to climb from US$199.8 million in 2022 to US$204.9 million in 2023. This positive trend is expected to continue, with a Compound Annual Growth Rate (CAGR) of 3.2% anticipated from 2023 to 2033. By 2033, the market is expected to reach a valuation of US$264.7 million.
The newest research from Future Market Insights (FMI) indicates that the worldwide market is expected to make a significant upswing, with a target value of US$ 281.3 million by the end of the projected year. The market value increase is indicative of the increasing global prevalence of cardiovascular illnesses.
The groundbreaking insights unveiled by FMI underscore the transformative potential of the dual balloon angioplasty catheters sector. With innovative technologies and advanced medical interventions driving progress, stakeholders anticipate a paradigm shift in cardiovascular care.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-4991
The market for Dual Balloon Angioplasty Catheter is less invasive than bypass surgery. Balloon angioplasty widens the limited blood vessel by inflating the balloon, which stretches the region in the artery. A Dual Balloon Angioplasty Catheter is a thin, flexible plastic tube with a small balloon attached to the tip. This tip is used to inject fluids and measure blood pressure.
Global Dual Balloon Angioplasty Catheter Industry Key Takeaways
- Because it avoids issues such as big catheter insertion and removal, the Dual Balloon Angioplasty Catheter is gaining acceptance in the healthcare profession. Stents are frequently placed directly on the tip of the balloon in this manner. An X-ray is used to guide the catheter into the heart and arteries during dual balloon angioplasty.
- To stop the bleeding, firm pressure is applied to the catheter. Dual balloon angioplasty is commonly used when a cholesterol plaque forms in the wall of a coronary artery. More blood and oxygen can now enter the heart muscles.
- Placing the Dual Balloon Angioplasty Catheter is straightforward. The market is growing due to an increase in the prevalence of cardiac problems and more effective medications that have a direct effect on the targeted area via soft and flexible catheters.
- It is expected that the peripheral and coronary angioplasty market will continue to develop in the future years, owing to an increase in cardiovascular disease, obesity, and diabetes, hence increasing the growth of the Global Dual Balloon Angioplasty Catheter Industry.
Global Dual Balloon Angioplasty Catheter Industry Competitive Landscape
Prominent companies in the Global Dual Balloon Angioplasty Catheter Industry continuously indulge in various collaborations with other dominant players. In addition to that, massive investments are being made in research and development activities that display more convenient solutions to industry verticals.
Some of the key participants present in the Global Dual Balloon Angioplasty Catheter Industry include Spectranetics, InSitu Technologies® Inc, eucatech AG, Balton Sp. z o.o., PanMed Us, Degania Silicone Ltd, Van Oostveen Medical B.V., IMeSI, phenox GmbH, Natec Medical, Acrostak Int., SCITECH., Medinol Ltd. among others.
Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/REP-GB-4991
More Insights into the Global Dual Balloon Angioplasty Catheter Industry
North America is predicted to occupy a dominant share of the Global Dual Balloon Angioplasty Catheter Industry by possessing over 31.8% of the total market. According to the FMI analysis, demand for balloon catheters will accelerate over the forecast years owing to the presence of leading manufacturers, increased patient awareness, availability of advanced healthcare facilities and infrastructure, and technological advancements.
Growth in the North American region is attributed to the rising awareness among patients about a variety of treatment options and general health awareness. Furthermore, the rising prevalence of related illnesses in the region is contributing to the growth of this region.
The European region is anticipated to be the second leading market accounting for about 21.9% of the market share in the Global Dual Balloon Angioplasty Catheter Industry. An increase in the aging population, efficient healthcare infrastructure and an emphasis on the development of innovative technology as well as enhanced patient diagnosis are responsible for the surge in the market.
The region is expected to witness phenomenal growth due to the increased emphasis on research and development along with the latest surgical inventions are fueling growth in the market. Moreover, Higher developmental capabilities in medical devices adoption of diverse healthcare technologies such as robotic-assisted surgical procedures, and rising expenditure on healthcare infrastructure development are expected to surge growth in the region.
The Asia Pacific is yet another region expected to show positive growth over the assessment years. Countries like China and India are expected to fuel market growth due to new product launches, acquisitions, distribution agreements, alliances, and geographical expansion by local players.
Key Segments Profiled in the Global Dual Balloon Angioplasty Catheter Industry Survey
Global Dual Balloon Angioplasty Catheter Industry by Indication:
- Peripheral Dual Balloon Angioplasty
- Coronal Dual Balloon Angioplasty
Global Dual Balloon Angioplasty Catheter Industry by End–User:
- Dual Balloon Angioplasty Catheter for Hospitals
- Dual Balloon Angioplasty Catheter for Catheterization Labs
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
